RegentAtlantic Capital’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.33M | Buy |
4,068
+705
| +21% | +$230K | 0.04% | 260 |
|
|
2022
Q2 | $1.18M | Buy |
3,363
+1,880
| +127% | +$660K | 0.04% | 286 |
|
|
2022
Q1 | $811K | Buy |
1,483
+77
| +5% | +$42.1K | 0.02% | 356 |
|
|
2021
Q4 | $926K | Sell |
1,406
-10
| -0.7% | -$6.59K | 0.03% | 337 |
|
|
2021
Q3 | $881K | Buy |
1,416
+194
| +16% | +$121K | 0.03% | 327 |
|
|
2021
Q2 | $772K | Buy |
1,222
+136
| +13% | +$85.9K | 0.02% | 334 |
|
|
2021
Q1 | $531K | Buy |
1,086
+224
| +26% | +$110K | 0.02% | 372 |
|
|
2020
Q4 | $431K | Buy |
862
+10
| +1% | +$5K | 0.02% | 363 |
|
|
2020
Q3 | $335K | Sell |
852
-2
| -0.2% | -$786 | 0.02% | 378 |
|
|
2020
Q2 | $282K | Buy |
+854
| New | +$282K | 0.02% | 396 |
|
|
2015
Q1 | – | Sell |
-30
| Closed | -$2.22K | – | 597 |
|
|
2014
Q4 | $2.22K | Buy |
+30
| New | +$2.22K | ﹤0.01% | 1117 |
|